Search

Search Constraints

You searched for: Author/Creator Ford, Janet H.

Search Results

2. Annual indirect cost savings in patients with episodic or chronic migraine: post-hoc analyses from multiple galcanezumab clinical trials. (31st December 2022)

7. Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine. Issue 10 (29th November 2020)